A Phase III Study of CM326 in Subjects With Moderate to Severe Asthma

NCT07372287 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

230

Enrollment

INDUSTRY

Sponsor class

Conditions

Moderate to Severe Asthma

Interventions

DRUG: CM326
OTHER: Placebo

Sponsor

CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.